GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
IT1016489B
(it)
|
1974-03-18 |
1977-05-30 |
Isf Spa |
Inalatore
|
ZA81219B
(en)
|
1980-01-23 |
1982-01-27 |
Schering Corp |
Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
WO1993019750A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic or inflammatory diseases
|
CZ283425B6
(cs)
|
1992-04-02 |
1998-04-15 |
Smithkline Beecham Corporation |
Fenylové deriváty a farmaceutické prostředky s jejich obsahem
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
US6596260B1
(en)
|
1993-08-27 |
2003-07-22 |
Novartis Corporation |
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
|
AU718682B2
(en)
|
1995-12-07 |
2000-04-20 |
Jagotec Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
CN1159076C
(zh)
|
1996-02-21 |
2004-07-28 |
先灵公司 |
粉状药物吸入器
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
WO2001013953A2
(en)
|
1999-08-21 |
2001-03-01 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
DK1040108T3
(da)
|
1997-12-19 |
2004-05-24 |
Schering Ag |
Orthoanthranilamidderivater som antikoagulanter
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
CA2335094C
(en)
|
1998-06-30 |
2008-12-23 |
The Dow Chemical Company |
Polymer polyols and a process for the production thereof
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
WO2000007991A1
(en)
|
1998-08-04 |
2000-02-17 |
Astrazeneca Ab |
Amide derivatives useful as inhibitors of the production of cytokines
|
ATE303357T1
(de)
|
1999-03-17 |
2005-09-15 |
|
Amid-derivate
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
SK286641B6
(sk)
|
1999-05-04 |
2009-03-05 |
Schering Corporation |
Piperazínové deriváty užitočné ako CCR5 antagonisty, farmaceutické prípravky s ich obsahom a ich použitie
|
WO2000066559A1
(en)
|
1999-05-04 |
2000-11-09 |
Schering Corporation |
Piperidine derivatives useful as ccr5 antagonists
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
DE19943639A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943636A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943634A1
(de)
|
1999-09-13 |
2001-04-12 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
WO2001019788A2
(en)
|
1999-09-17 |
2001-03-22 |
Cor Therapeutics, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
GB9924092D0
(en)
|
1999-10-13 |
1999-12-15 |
Zeneca Ltd |
Pyrimidine derivatives
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
WO2001083462A1
(de)
|
2000-04-27 |
2001-11-08 |
Boehringer Ingelheim Pharma Kg |
Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
SI1300407T2
(sl)
|
2000-06-27 |
2011-09-30 |
S A L V A T Lab Sa |
Karbamati, izvedeni iz arilalkilaminov
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
EA005992B1
(ru)
|
2000-08-05 |
2005-08-25 |
Глаксо Груп Лимитед |
S-ФТОРМЕТИЛОВЫЙ ЭФИР 6α,9α-ДИФТОР-17α-[(2-ФУРАНИЛКАРБОНИЛ)ОКСИ]-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОКИСЛОТЫ В КАЧЕСТВЕ ПРОТИВОВОСПАЛИТЕЛЬНОГО АГЕНТА
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
RU2296762C2
(ru)
|
2000-12-22 |
2007-04-10 |
Альмиралль Продесфарма Аг |
Карбаматы хинуклидина, способы их получения и фармацевтическая композиция на их основе
|
BR0116624A
(pt)
|
2000-12-28 |
2003-12-23 |
Almirall Prodesfarma Ag |
Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto ou da composição farmacêutica, e, produto de combinação
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
SE0100567D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
ES2296923T3
(es)
|
2001-03-22 |
2008-05-01 |
Glaxo Group Limited |
Derivados formanilidas como agonistas del adrenorreceptor beta2.
|
EP2039700A2
(en)
|
2001-04-30 |
2009-03-25 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
WO2002100879A1
(en)
|
2001-06-12 |
2002-12-19 |
Glaxo Group Limited |
Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
|
EP2327766B1
(en)
|
2001-06-21 |
2015-12-02 |
BASF Enzymes LLC |
Nitrilases
|
CA2458534C
(en)
|
2001-09-14 |
2011-11-01 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
RU2004110717A
(ru)
|
2001-10-17 |
2005-10-20 |
Юсиби, С.А. (Be) |
Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
BR0215348A
(pt)
|
2001-12-20 |
2004-11-16 |
S A L V A T Lab Sa |
Derivados de carbamato de 1-alquil-1-azoniabiciclo[2-2]octano e uso destes como antagonistas do receptor muscarìnico
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1485384A1
(en)
|
2002-03-13 |
2004-12-15 |
Pharmacia & Upjohn Company LLC |
Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
|
CN1633296A
(zh)
|
2002-03-26 |
2005-06-29 |
贝林格尔·英格海姆药物公司 |
糖皮质素模拟物、其制备方法、药物组合物及其用途
|
AU2003230700A1
(en)
|
2002-03-26 |
2003-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP1496892B1
(en)
|
2002-04-11 |
2011-01-26 |
Merck Sharp & Dohme Corp. |
1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
ES2298511T3
(es)
|
2002-04-25 |
2008-05-16 |
Glaxo Group Limited |
Derivados de fenetanolamina.
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
AU2003239880A1
(en)
|
2002-05-28 |
2003-12-12 |
Theravance, Inc. |
ALKOXY ARYL Beta2 ADRENERGIC RECEPTOR AGONISTS
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
EP1517895B1
(en)
|
2002-06-25 |
2007-03-14 |
Merck Frosst Canada Ltd. |
8-(biaryl) quinoline pde4 inhibitors
|
CA2490097A1
(en)
|
2002-07-02 |
2004-01-15 |
Merck Frosst Canada & Co. |
Di-aryl-substituted-ethane pyridone pde4 inhibitors
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
ES2518940T3
(es)
|
2002-07-08 |
2014-11-06 |
Pfizer Products Inc. |
Moduladores del receptor de glucocorticoides
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(es)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
|
ES2286491T3
(es)
|
2002-08-10 |
2007-12-01 |
Nycomed Gmbh |
Piperidina-ftalazonas sustituidas con pirrolidinadiona, como agentes inhibidores de la pde4.
|
CA2494650A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Pyridazinone-derivatives as pde4 inhibitors
|
WO2004018450A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
WO2004018449A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
CA2495597A1
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Novel phenanthridines
|
JP2005537313A
(ja)
|
2002-08-17 |
2005-12-08 |
アルタナ ファルマ アクチエンゲゼルシャフト |
新規のベンゾナフチリジン
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
WO2004018429A2
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
WO2004018422A1
(en)
|
2002-08-23 |
2004-03-04 |
Ranbaxy Laboratories Limited |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
WO2004019945A1
(en)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
DE60333371D1
(de)
|
2002-08-29 |
2010-08-26 |
Boehringer Ingelheim Pharma |
3-(sulfonamidoethyl)-indol-derivate zur verwendung als glucocorticoid-mimetika bei der behandlung von entzündlichen, allergischen und proliferativen erkrankungen
|
WO2004019944A1
(en)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
JPWO2004026873A1
(ja)
|
2002-09-18 |
2006-01-19 |
小野薬品工業株式会社 |
トリアザスピロ[5.5]ウンデカン誘導体およびそれらを有効成分とする薬剤
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
CN100549011C
(zh)
|
2002-09-19 |
2009-10-14 |
先灵公司 |
用作细胞周期蛋白依赖性激酶抑制剂的新颖咪唑并吡啶
|
TWI283243B
(en)
|
2002-09-19 |
2007-07-01 |
Schering Corp |
Novel pyrazolopyridines as cyclin dependent kinase inhibitors
|
JP4520309B2
(ja)
|
2002-09-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的糖質コルチコイド受容体調節剤としてのオクタヒドロ−2−H−ナフト[1,2−f]インドール−4−カルボキサミド誘導体
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
KR20050047552A
(ko)
|
2002-10-11 |
2005-05-20 |
화이자 인코포레이티드 |
베타-2 작용제로서의 인돌 유도체
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
WO2004037807A2
(en)
|
2002-10-22 |
2004-05-06 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
EA010408B1
(ru)
|
2002-10-23 |
2008-08-29 |
Гленмарк Фармасьютикалс Лтд. |
Трициклические соединения для лечения воспалительных и аллергических нарушений, способы их приготовления и содержащие их фармацевтические составы
|
KR20050057681A
(ko)
|
2002-10-28 |
2005-06-16 |
글락소 그룹 리미티드 |
호흡기 질환의 치료에 유용한 페네탄올아민 유도체
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
TWI299664B
(en)
|
2003-01-06 |
2008-08-11 |
Osi Pharm Inc |
(2-carboxamido)(3-amino)thiophene compounds
|
JP4606408B2
(ja)
|
2003-01-21 |
2011-01-05 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的グルココルチコイド受容体調節物質としての17−カルバモイルオキシコルチゾル誘導体
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
CA2514733A1
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
JP4705015B2
(ja)
|
2003-04-03 |
2011-06-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
カルボニル化合物
|
EP1479680A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
Azaindole derivatives as Factor Xa inhibitors
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
EP1636269A2
(en)
|
2003-06-10 |
2006-03-22 |
Ace Biosciences A/S |
Extracellular aspergillus polypeptides
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US20050267182A1
(en)
|
2003-11-13 |
2005-12-01 |
Ambit Biosciences Corporation |
Urea derivatives as FLT-3 modulators
|
EP1699780A1
(en)
|
2003-12-23 |
2006-09-13 |
Pfizer, Inc. |
Novel quinoline derivatives
|
US20070185152A1
(en)
|
2004-03-02 |
2007-08-09 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
GB0410712D0
(en)
|
2004-05-13 |
2004-06-16 |
Novartis Ag |
Organic compounds
|
DE102004045796A1
(de)
|
2004-09-22 |
2006-03-23 |
Merck Patent Gmbh |
Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
|
CA2589773A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
RU2368602C2
(ru)
|
2005-01-26 |
2009-09-27 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов протеинкиназ
|
TW200714600A
(en)
|
2005-03-21 |
2007-04-16 |
S Bio Pte Ltd |
Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
JP2009502843A
(ja)
*
|
2005-07-29 |
2009-01-29 |
エフ.ホフマン−ラ ロシュ アーゲー |
アザベンズイミダゾール誘導体、それらの製造、及び抗癌剤としての使用
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
WO2007032936A2
(en)
|
2005-09-09 |
2007-03-22 |
Schering Corporation |
Azafused cyclin dependent kinase inhibitors
|
CA2629743A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
|
US20090170847A1
(en)
*
|
2006-01-23 |
2009-07-02 |
Seung Chul Lee |
Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same
|
GB0604937D0
(en)
|
2006-03-10 |
2006-04-19 |
Novartis Ag |
Organic compounds
|
MX2008012617A
(es)
|
2006-03-31 |
2008-10-10 |
Novartis Ag |
Compuestos organicos.
|
US20080015193A1
(en)
|
2006-06-20 |
2008-01-17 |
Mendoza Jose S |
Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
CA2662031A1
(en)
*
|
2006-09-06 |
2008-03-13 |
F. Hoffmann-La Roche Ag |
Heteroaryl derivatives as protein kinase inhibitors
|
KR20090075889A
(ko)
|
2006-11-03 |
2009-07-09 |
아이알엠 엘엘씨 |
단백질 키나제 억제제로서의 화합물 및 조성물
|
ME01507B
(me)
|
2006-11-22 |
2014-04-20 |
Incyte Holdings Corp |
Imidazotriazini i imidazopirimidini kao inhibitori kinaze
|
CA2672213C
(en)
|
2006-12-22 |
2016-02-16 |
Astex Therapeutics Limited |
Bicyclic amine derivatives as protein tyrosine kinase inhibitors
|
ES2449482T3
(es)
|
2007-01-09 |
2014-03-19 |
Amgen Inc. |
Derivados de bis-aril-amida útiles para el tratamiento de cáncer
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
WO2008150015A1
(en)
|
2007-06-05 |
2008-12-11 |
Takeda Pharmaceutical Company Limited |
Heterobicyclic compounds as kinase inhibitors
|
CN101765585B
(zh)
|
2007-06-12 |
2017-03-15 |
尔察祯有限公司 |
抗菌剂
|
BRPI0814423B1
(pt)
|
2007-07-17 |
2022-04-19 |
Plexxikon, Inc |
Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
|
CN101945848A
(zh)
|
2007-12-20 |
2011-01-12 |
英维沃医药有限公司 |
四取代的苯
|
US20100324086A1
(en)
|
2008-02-19 |
2010-12-23 |
Novasaid Ab |
Compounds and methods
|
CA2722418C
(en)
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
EP2320907A4
(en)
|
2008-08-05 |
2012-09-05 |
Merck Sharp & Dohme |
THERAPEUTIC COMPOUNDS
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
GEP201706639B
(en)
|
2009-08-17 |
2017-03-27 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
EP2579888A2
(en)
|
2010-06-09 |
2013-04-17 |
Receptos, Inc. |
Novel glp-1 receptor stabilizers and modulators
|
SG186989A1
(en)
|
2010-07-14 |
2013-02-28 |
Novartis Ag |
Ip receptor agonist heterocyclic compounds
|
KR102008946B1
(ko)
*
|
2010-08-03 |
2019-08-08 |
노브알리스 도이칠란트 게엠베하 |
친화성 크로마토그래피에 의한 항체 및 Fc-융합 단백질 정제용 리간드
|
US8809541B2
(en)
|
2010-08-25 |
2014-08-19 |
Neopharm Co., Ltd. |
Heterocyclic compound, and composition for treating inflammatory diseases using same
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
US8883819B2
(en)
*
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|